1. Preface
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
3. Executive Summary
4. Global Diabetes Care Devices Market – Introduction
4.1. What are Diabetes Care Devices?
4.1.1. Introduction
4.1.2. Major Applications
4.2. Industry Trends
4.3. Competitive Intelligence
5. Global Diabetes Care Devices Market Landscape
5.1. Historical and Current Market Trends (2018-2023)
5.2. Market Forecast (2024-2032)
6. Global Diabetes Care Devices Market - Breakup by Type
6.1. Blood Glucose Monitoring (BGM) Devices
6.1.1. Overview
6.1.2. Historical and Current Market Trends (2018-2023)
6.1.3. Blood Glucose Monitoring (BGM) Devices Market – Key Segments
6.1.3.1. Self-Monitoring Devices
6.1.3.2. Continuous Glucose Monitoring Devices
6.1.4. Market Forecast (2024-2032)
6.1.5. Market Breakup by Distribution Channel
6.1.6. Market Breakup by End User
6.1.7. Key Players
6.1.8. Patent Analysis
6.1.8.1. Top Patent Applications
6.1.8.2. Document Type
6.1.8.3. Jurisdiction Analysis
6.1.8.4. Top CPC Codes
6.1.8.5. Legal status
6.2. Insulin Delivery Devices
6.2.1. Overview
6.2.2. Historical and Current Market Trends (2018-2023)
6.2.3. Insulin Delivery Devices Market – Key Segments
6.2.3.1. Pumps
6.2.3.2. Pens
6.2.3.3. Syringes
6.2.3.4. Jet Injectors
6.2.4. Market Forecast (2024-2032)
6.2.5. Market Breakup by Distribution Channel
6.2.6. Market Breakup by End User
6.2.7. Key Players
6.2.8. Patent Analysis
6.2.8.1. Top Patent Applications
6.2.8.2. Document Type
6.2.8.3. Jurisdiction Analysis
6.2.8.4. Top CPC Codes
6.2.8.5. Legal status
6.3. Attractive Investment Proposition by Type
7. Global Diabetes Care Devices Market - Breakup by Distribution Channel
7.1. Retail
7.1.1. Overview
7.1.2. Historical and Current Market Trends (2018-2023)
7.1.3. Market Forecast (2024-2032)
7.1.4. Market Breakup by Type
7.1.5. Market Breakup by End User
7.1.6. Key Players
7.2. Institutional
7.2.1. Overview
7.2.2. Historical and Current Market Trends (2018-2023)
7.2.3. Market Forecast (2024-2032)
7.2.4. Market Breakup by Type
7.2.5. Market Breakup by End User
7.2.6. Key Players
7.3. Attractive Investment Proposition by Distribution Channel
8. Global Diabetes Care Devices Market - Breakup by End User
8.1. Hospitals
8.1.1. Overview
8.1.2. Historical and Current Market Trends (2018-2023)
8.1.3. Market Forecast (2024-2032)
8.1.4. Market Breakup by Type
8.1.5. Market Breakup by Distribution Channel
8.1.6. Key Players
8.2. Homecare
8.2.1. Overview
8.2.2. Historical and Current Market Trends (2018-2023)
8.2.3. Market Forecast (2024-2032)
8.2.4. Market Breakup by Type
8.2.5. Market Breakup by Distribution Channel
8.2.6. Key Players
8.3. Diagnostic Centres
8.3.1. Overview
8.3.2. Historical and Current Market Trends (2018-2023)
8.3.3. Market Forecast (2024-2032)
8.3.4. Market Breakup by Type
8.3.5. Market Breakup by Distribution Channel
8.3.6. Key Players
8.4. Ambulatory Surgery Centres
8.4.1. Overview
8.4.2. Historical and Current Market Trends (2018-2023)
8.4.3. Market Forecast (2024-2032)
8.4.4. Market Breakup by Type
8.4.5. Market Breakup by Distribution Channel
8.4.6. Key Players
8.4.7. Patent Analysis
8.5. Attractive Investment Proposition by End User
9. Global Diabetes Care Devices Market – Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Patient Cases of Diabetes
9.1.1.2. Market Drivers
9.1.1.3. Historical and Current Market Trends (2018-2023)
9.1.1.4. Market Breakup by Type
9.1.1.5. Market Breakup by Distribution Channel
9.1.1.6. Market Breakup by End User
9.1.1.7. Key Players
9.1.1.8. Market Forecast (2024-2032)
9.1.1.9. Recent Investments
9.1.1.9.1. Government Investments
9.1.1.9.2. Private Investments
9.1.1.10. Regulatory Approval Process
9.1.1.11. Pricing Analysis
9.1.2. Canada
9.1.2.1. Market Drivers
9.1.2.2. Historical and Current Market Trends (2018-2023)
9.1.2.3. Market Breakup by Type
9.1.2.4. Market Breakup by Distribution Channel
9.1.2.5. Market Breakup by End User
9.1.2.6. Key Players
9.1.2.7. Market Forecast (2024-2032)
9.1.2.8. Recent Investments
9.1.2.8.1. Government Investments
9.1.2.8.2. Private Investments
9.1.2.9. Regulatory Approval Process
9.1.2.10. Pricing Analysis
9.2. Europe
9.2.1. Germany
9.2.1.1. Patient Cases of Diabetes
9.2.1.2. Market Drivers
9.2.1.3. Historical and Current Market Trends (2018-2023)
9.2.1.4. Market Breakup by Type
9.2.1.5. Market Breakup by Distribution Channel
9.2.1.6. Market Breakup by End User
9.2.1.7. Key Players
9.2.1.8. Market Forecast (2024-2032)
9.2.1.9. Recent Investments
9.2.1.9.1. Government Investments
9.2.1.9.2. Private Investments
9.2.1.10. Regulatory Approval Process
9.2.1.11. Pricing Analysis
9.2.2. France
9.2.2.1. Patient Cases of Diabetes
9.2.2.2. Market Drivers
9.2.2.3. Historical and Current Market Trends (2018-2023)
9.2.2.4. Market Breakup by Type
9.2.2.5. Market Breakup by Distribution Channel
9.2.2.6. Market Breakup by End User
9.2.2.7. Key Players
9.2.2.8. Market Forecast (2024-2032)
9.2.2.9. Recent Investments
9.2.2.9.1. Government Investments
9.2.2.9.2. Private Investments
9.2.2.10. Regulatory Approval Process
9.2.2.11. Pricing Analysis
9.2.3. United Kingdom
9.2.3.1. Patient Cases of Diabetes
9.2.3.2. Market Drivers
9.2.3.3. Historical and Current Market Trends (2018-2023)
9.2.3.4. Market Breakup by Type
9.2.3.5. Market Breakup by Distribution Channel
9.2.3.6. Market Breakup by End User
9.2.3.7. Key Players
9.2.3.8. Market Forecast (2024-2032)
9.2.3.9. Recent Investments
9.2.3.9.1. Government Investments
9.2.3.9.2. Private Investments
9.2.3.10. Regulatory Approval Process
9.2.3.11. Pricing Analysis
9.2.4. Italy
9.2.4.1. Patient Cases of Diabetes
9.2.4.2. Market Drivers
9.2.4.3. Historical and Current Market Trends (2018-2023)
9.2.4.4. Market Breakup by Type
9.2.4.5. Market Breakup by Distribution Channel
9.2.4.6. Market Breakup by End User
9.2.4.7. Key Players
9.2.4.8. Market Forecast (2024-2032)
9.2.4.9. Recent Investments
9.2.4.9.1. Government Investments
9.2.4.9.2. Private Investments
9.2.4.10. Regulatory Approval Process
9.2.4.11. Pricing Analysis
9.2.5. Spain
9.2.5.1. Patient Cases of Diabetes
9.2.5.2. Market Drivers
9.2.5.3. Historical and Current Market Trends (2018-2023)
9.2.5.4. Market Breakup by Type
9.2.5.5. Market Breakup by Distribution Channel
9.2.5.6. Market Breakup by End User
9.2.5.7. Key Players
9.2.5.8. Market Forecast (2024-2032)
9.2.5.9. Recent Investments
9.2.5.9.1. Government Investments
9.2.5.9.2. Private Investments
9.2.5.10. Regulatory Approval Process
9.2.5.11. Pricing Analysis
9.2.6. Russia
9.2.6.1. Market Drivers
9.2.6.2. Historical and Current Market Trends (2018-2023)
9.2.6.3. Market Breakup by Type
9.2.6.4. Market Breakup by Distribution Channel
9.2.6.5. Market Breakup by End User
9.2.6.6. Key Players
9.2.6.7. Market Forecast (2024-2032)
9.2.6.8. Recent Investments
9.2.6.8.1. Government Investments
9.2.6.8.2. Private Investments
9.2.6.9. Regulatory Approval Process
9.2.6.10. Pricing Analysis
9.2.7. Others
9.2.7.1. Historical and Current Market Trends (2018-2023)
9.2.7.2. Market Forecast (2024-2032)
9.3. Asia Pacific
9.3.1. China
9.3.1.1. Market Drivers
9.3.1.2. Historical and Current Market Trends (2018-2023)
9.3.1.3. Market Breakup by Type
9.3.1.4. Market Breakup by Distribution Channel
9.3.1.5. Market Breakup by End User
9.3.1.6. Key Players
9.3.1.7. Market Forecast (2024-2032)
9.3.1.8. Recent Investments
9.3.1.8.1. Government Investments
9.3.1.8.2. Private Investments
9.3.1.9. Regulatory Approval Process
9.3.1.10. Pricing Analysis
9.3.2. Japan
9.3.2.1. Market Drivers
9.3.2.2. Historical and Current Market Trends (2018-2023)
9.3.2.3. Market Breakup by Type
9.3.2.4. Market Breakup by Distribution Channel
9.3.2.5. Market Breakup by End User
9.3.2.6. Key Players
9.3.2.7. Market Forecast (2024-2032)
9.3.2.8. Recent Investments
9.3.2.8.1. Government Investments
9.3.2.8.2. Private Investments
9.3.2.9. Regulatory Approval Process
9.3.2.10. Pricing Analysis
9.3.3. India
9.3.3.1. Market Drivers
9.3.3.2. Historical and Current Market Trends (2018-2023)
9.3.3.3. Market Breakup by Type
9.3.3.4. Market Breakup by Distribution Channel
9.3.3.5. Market Breakup by End User
9.3.3.6. Key Players
9.3.3.7. Market Forecast (2024-2032)
9.3.3.8. Recent Investments
9.3.3.8.1. Government Investments
9.3.3.8.2. Private Investments
9.3.3.9. Regulatory Approval Process
9.3.3.10. Pricing Analysis
9.3.4. South Korea
9.3.4.1. Market Drivers
9.3.4.2. Historical and Current Market Trends (2018-2023)
9.3.4.3. Market Breakup by Type
9.3.4.4. Market Breakup by Distribution Channel
9.3.4.5. Market Breakup by End User
9.3.4.6. Key Players
9.3.4.7. Market Forecast (2024-2032)
9.3.4.8. Recent Investments
9.3.4.8.1. Government Investments
9.3.4.8.2. Private Investments
9.3.4.9. Regulatory Approval Process
9.3.4.10. Pricing Analysis
9.3.5. Australia
9.3.5.1. Market Drivers
9.3.5.2. Historical and Current Market Trends (2018-2023)
9.3.5.3. Market Breakup by Type
9.3.5.4. Market Breakup by Distribution Channel
9.3.5.5. Market Breakup by End User
9.3.5.6. Key Players
9.3.5.7. Market Forecast (2024-2032)
9.3.5.8. Recent Investments
9.3.5.8.1. Government Investments
9.3.5.8.2. Private Investments
9.3.5.9. Regulatory Approval Process
9.3.5.10. Pricing Analysis
9.3.6. Indonesia
9.3.6.1. Market Drivers
9.3.6.2. Historical and Current Market Trends (2018-2023)
9.3.6.3. Market Breakup by Type
9.3.6.4. Market Breakup by Distribution Channel
9.3.6.5. Market Breakup by End User
9.3.6.6. Key Players
9.3.6.7. Market Forecast (2024-2032)
9.3.6.8. Recent Investments
9.3.6.8.1. Government Investments
9.3.6.8.2. Private Investments
9.3.6.9. Regulatory Approval Process
9.3.6.10. Pricing Analysis
9.3.7. Others
9.3.7.1. Historical and Current Market Trends (2018-2023)
9.3.7.2. Market Forecast (2024-2032)
9.4. Latin America
9.4.1. Brazil
9.4.1.1. Market Drivers
9.4.1.2. Historical and Current Market Trends (2018-2023)
9.4.1.3. Market Breakup by Type
9.4.1.4. Market Breakup by Distribution Channel
9.4.1.5. Market Breakup by End User
9.4.1.6. Key Players
9.4.1.7. Market Forecast (2024-2032)
9.4.1.8. Recent Investments
9.4.1.8.1. Government Investments
9.4.1.8.2. Private Investments
9.4.1.9. Regulatory Approval Process
9.4.1.10. Pricing Analysis
9.4.2. Mexico
9.4.2.1. Market Drivers
9.4.2.2. Historical and Current Market Trends (2018-2023)
9.4.2.3. Market Breakup by Type
9.4.2.4. Market Breakup by Distribution Channel
9.4.2.5. Market Breakup by End User
9.4.2.6. Key Players
9.4.2.7. Market Forecast (2024-2032)
9.4.2.8. Recent Investments
9.4.2.8.1. Government Investments
9.4.2.8.2. Private Investments
9.4.2.9. Regulatory Approval Process
9.4.2.10. Pricing Analysis
9.4.3. Others
9.4.3.1. Historical and Current Market Trends (2018-2023)
9.4.3.2. Market Forecast (2024-2032)
9.5. Middle East
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2018-2023)
9.5.3 Market Breakup by Type
9.5.4 Market Breakup by Distribution Channel
9.5.5 Market Breakup by End User
9.5.6 Market Breakup by Country
9.5.7 Key Players
9.5.8 Market Forecast (2024-2032)
9.5.9 Recent Investments
9.5.9.1 Government Investments
9.5.9.2 Private Investments
9.5.10 Regulatory Approval Process
9.5.11 Pricing Analysis
9.6. Africa
9.6.1 Market Drivers
9.6.2 Historical and Current Market Trends (2018-2023)
9.6.3 Market Breakup by Type
9.6.4 Market Breakup by Distribution Channel
9.6.5 Market Breakup by End User
9.6.6 Market Breakup by Country
9.6.7 Key Players
9.6.8 Market Forecast (2024-2032)
9.6.9 Recent Investments
9.6.9.1 Government Investments
9.6.9.2 Private Investments
9.6.12 Regulatory Approval Process
9.6.13 Pricing Analysis
9.7. Attractive Investment Proposition by Region
10. Technology Analysis
10.1. Overview of Different Technologies
10.2. Technology wise Diabetes Care Applications
10.3. Time to Market for New Product
10.4. Key Technology Trends
10.4.1. Continuous Glucose Monitoring (CGM) Technology
10.4.2. Emerging Technologies like AI and Machine Learning
10.4.3. Remote Patient Monitoring (RPM) Technology
11. Government Regulations and Strategies
12. Global Diabetes Care Devices Market - Industry Analysis
12.1. Drivers, Restraints, and Opportunities
12.1.1. Overview
12.1.2. Drivers
12.1.2.1. Rising Prevalence of Diabetes
12.1.2.2. Growing Adoption of Self-Monitoring Devices
12.1.2.3. Increasing Awareness and Education
12.1.3. Restraints
12.1.3.1. High Cost of Devices
12.1.3.2. Inadequate Access to Healthcare Facilities
12.1.3.3. Strict Regulation Guidelines for Medical Devices
12.1.4. Opportunities
12.1.4.1. Continued Innovation in Diabetes Care Devices
12.1.4.2. Increasing Awareness of Diabetes in Emerging Markets
12.1.5. Impact Analysis
12.2. Porters Five Forces Analysis
12.2.1. Overview
12.2.2. Bargaining Power of Buyers
12.2.3. Bargaining Power of Suppliers
12.2.4. Degree of Competition
12.2.5. Threat of New Entrants
12.2.6. Threat of Substitutes
12.3. Value Chain Analysis
13. Global Diabetes Care Devices Market – Competitive Landscape
13.1. Overview
13.2. Market Structure
13.3. Market Share by Key Players
13.4. Market Player Positioning
13.5. Top Winning Strategies
13.6. Competitive Dashboard
13.7. Company Evaluation Quadrant
14. Profiles of Key Players
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Products Offered
14.1.3. Business Strategies
14.1.3.1. Marketing Strategy
14.1.3.2. Product Strategy
14.1.3.3. Channel Strategy
14.1.4. Financials
14.1.5. SWOT Analysis
14.1.6. Major News and Events
14.2. ACON Laboratories Inc.
14.2.1. Business Overview
14.2.2. Products Offered
14.2.3. Business Strategies
14.2.3.1. Marketing Strategy
14.2.3.2. Product Strategy
14.2.3.3. Channel Strategy
14.2.4. SWOT Analysis
14.2.5. Major News and Events
14.3. Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
14.3.1. Business Overview
14.3.2. Products Offered
14.3.3. Business Strategies
14.3.3.1. Marketing Strategy
14.3.3.2. Product Strategy
14.3.3.3. Channel Strategy
14.3.4. SWOT Analysis
14.3.5. Major News and Events
14.4. Becton Dickinson and Company
14.4.1. 13.4.1 Business Overview
14.4.2. Products Offered
14.4.3. Business Strategies
14.4.3.1. Marketing Strategy
14.4.3.2. Product Strategy
14.4.3.3. Channel Strategy
14.4.4. Financials
14.4.5. SWOT Analysis
14.4.6. Major News and Events
14.5. Bionime Corporation
14.5.1. Business Overview
14.5.2. Products Offered
14.5.3. Business Strategies
14.5.3.1. Marketing Strategy
14.5.3.2. Product Strategy
14.5.3.3. Channel Strategy
14.5.4. SWOT Analysis
14.5.5. Major News and Events
14.6. Dexcom Inc.
14.6.1. Business Overview
14.6.2. Products Offered
14.6.3. Business Strategies
14.6.3.1. Marketing Strategy
14.6.3.2. Product Strategy
14.6.3.3. Channel Strategy
14.6.4. SWOT Analysis
14.6.5. Major News and Events
14.7. F. Hoffmann-La Roche AG
14.7.1. Business Overview
14.7.2. Products Offered
14.7.3. Business Strategies
14.7.3.1. Marketing Strategy
14.7.3.2. Product Strategy
14.7.3.3. Channel Strategy
14.7.4. Financials
14.7.5. SWOT Analysis
14.7.6. Major News and Events
14.8. Johnson & Johnson
14.8.1. Business Overview
14.8.2. Products Offered
14.8.3. Business Strategies
14.8.3.1. Marketing Strategy
14.8.3.2. Product Strategy
14.8.3.3. Channel Strategy
14.8.4. Financials
14.8.5. SWOT Analysis
14.8.6. Major News and Events
14.9. Medtronic plc
14.9.1. Business Overview
14.9.2. Products Offered
14.9.3. Business Strategies
14.9.3.1. Marketing Strategy
14.9.3.2. Product Strategy
14.9.3.3. Channel Strategy
14.9.4. Financials
14.9.5. SWOT Analysis
14.9.6. Major News and Events
14.10. Novo Nordisk A/S
14.10.1. Business Overview
14.10.2. Product Portfolio
14.10.3. Business Strategies
14.10.3.1. Marketing Strategy
14.10.3.2. Product Strategy
14.10.3.3. Channel Strategy
14.10.4. Financials
14.10.5. SWOT Analysis
14.10.6. Major News and Events
14.11. Sinocare Inc.
14.11.1. Business Overview
14.11.2. Product Portfolio
14.11.3. Business Strategies
14.11.3.1. Marketing Strategy
14.11.3.2. Product Strategy
14.11.3.3. Channel Strategy
14.11.4. SWOT Analysis
14.11.5. Major News and Events
14.12. Terumo Corporation
14.12.1. Business Overview
14.12.2. Product Portfolio
14.12.3. Business Strategies
14.12.3.1. Marketing Strategy
14.12.3.2. Product Strategy
14.12.3.3. Channel Strategy
14.12.4. Financials
14.12.5. SWOT Analysis
14.12.6. Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
15. Strategic Recommendations
16. Appendix